LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

Search

Teleflex Inc

Geschlossen

BrancheGesundheitswesen

111.63 -0.81

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

111.14

Max

113.46

Schlüsselkennzahlen

By Trading Economics

Einkommen

-531M

-409M

Verkäufe

132M

913M

KGV

Branchendurchschnitt

28.636

110.024

Dividendenrendite

1.3

Gewinnspanne

-44.785

Angestellte

14,100

EBITDA

-546M

-323M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

+10.76% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

1.30%

2.26%

Nächstes Ergebnis

26. Feb. 2026

Nächste Dividendenausschüttung

16. März 2026

Nächstes Ex-Dividendendatum

6. März 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-844M

4.6B

Vorheriger Eröffnungskurs

112.44

Vorheriger Schlusskurs

111.63

Nachrichtenstimmung

By Acuity

8%

92%

5 / 351 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

Teleflex Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

23. Feb. 2026, 22:53 UTC

Akquisitionen, Fusionen, Übernahmen

Keurig Dr Pepper Raises Additional $1.5 Billion in Deal to Split Company

23. Feb. 2026, 22:36 UTC

Ergebnisse

Kratos Defense & Security Solutions 4Q Profit Rises; Sees Federal Shutdown Denting 1Q -- Update

23. Feb. 2026, 22:32 UTC

Ergebnisse

Woodside Energy Fiscal Year Net Profit Falls 24%

23. Feb. 2026, 23:58 UTC

Market Talk
Ergebnisse

Plenty of Questions for Woodside Despite Well-Guided Result -- Market Talk

23. Feb. 2026, 23:58 UTC

Market Talk
Ergebnisse

Global Energy Roundup: Market Talk

23. Feb. 2026, 23:47 UTC

Market Talk

Scentre's Share Price Slips as Earnings Guidance Underwhelms -- Market Talk

23. Feb. 2026, 23:43 UTC

Market Talk

Gold Edges Higher Amid Ongoing Tariff Risks -- Market Talk

23. Feb. 2026, 23:41 UTC

Akquisitionen, Fusionen, Übernahmen

Crescent Capital Partners Owns 53% of ClearView Wealth

23. Feb. 2026, 23:40 UTC

Akquisitionen, Fusionen, Übernahmen

ClearView Wealth Says Crescent Capital Partners Intends to Support Deal

23. Feb. 2026, 23:40 UTC

Akquisitionen, Fusionen, Übernahmen

ClearView Wealth Says Directors Unanimously Recommend Shareholders Vote in Favor of Deal

23. Feb. 2026, 23:40 UTC

Market Talk

Nikkei May Rise as Investors Assess Tariff Developments -- Market Talk

23. Feb. 2026, 23:40 UTC

Akquisitionen, Fusionen, Übernahmen

ClearView Wealth Says Zurich Insurance Offering A$0.65/Share in Cash

23. Feb. 2026, 23:39 UTC

Akquisitionen, Fusionen, Übernahmen

ClearView Wealth Agrees to Takeover by Zurich Insurance Group Unit

23. Feb. 2026, 23:31 UTC

Ergebnisse

United Overseas Bank 2025 Total Dividend S$1.56/Shr >U11.SG

23. Feb. 2026, 23:31 UTC

Ergebnisse

United Overseas Bank Proposes Final Dividend of S$0.71/Shr Vs. S$0.92/Shr >U11.SG

23. Feb. 2026, 23:28 UTC

Ergebnisse

United Overseas Bank 4Q Net Interest Income S$2.35B Vs. S$2.45B >U11.SG

23. Feb. 2026, 23:28 UTC

Ergebnisse

United Overseas Bank 4Q Oper Pft S$1.76B Vs. Pft S$1.88B >U11.SG

23. Feb. 2026, 23:28 UTC

Ergebnisse

United Overseas Bank 4Q Total Income S$3.29B Vs. S$3.46B >U11.SG

23. Feb. 2026, 23:27 UTC

Ergebnisse

United Overseas Bank 4Q Net S$1.41B Vs. Net S$1.52B >U11.SG

23. Feb. 2026, 23:24 UTC

Market Talk

Major Miners On Whole Delivered Positive Earnings Season -- Market Talk

23. Feb. 2026, 22:38 UTC

Akquisitionen, Fusionen, Übernahmen

Keurig Dr Pepper Raises Additional $1.5B in Deal to Split Company

23. Feb. 2026, 22:31 UTC

Ergebnisse

Hims & Hers Stock Falls. Why Earnings Are Underwhelming Investors. -- Barrons.com

23. Feb. 2026, 22:24 UTC

Ergebnisse

Viva Energy Energy & Infrastructure Ebitda A$93 Million

23. Feb. 2026, 22:22 UTC

Ergebnisse

Viva Energy FY Commercial & Industrial Ebitda A$460.5 Million

23. Feb. 2026, 22:22 UTC

Ergebnisse

Viva Energy FY Convenience & Mobility Ebitda A$197.4 Million

23. Feb. 2026, 22:22 UTC

Ergebnisse

Viva Energy FY Underlying Ebitda A$700.9 Million

23. Feb. 2026, 22:22 UTC

Ergebnisse

Viva Energy Final Dividend 3.94 Australian Cents/Security

23. Feb. 2026, 22:21 UTC

Ergebnisse

Viva Energy FY Revenue A$28.53 Billion, Down 1.1%

23. Feb. 2026, 22:21 UTC

Ergebnisse

Viva Energy FY Replacement-Cost Net Profit A$183.6 Million, Down 28%

23. Feb. 2026, 22:20 UTC

Ergebnisse

Viva Energy FY Historical-Cost Net Loss A$421.1 Million

Peer-Vergleich

Kursveränderung

Teleflex Inc Prognose

Kursziel

By TipRanks

10.76% Vorteil

12-Monats-Prognose

Durchschnitt 125.2 USD  10.76%

Hoch 138 USD

Tief 115 USD

Basierend auf 6 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Teleflex Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

6 ratings

1

Buy

4

Halten

1

Sell

Technischer Score

By Trading Central

122.73 / 135.75Unterstützung & Widerstand

Kurzfristig

Very Strong Bearish Evidence

Mittelfristig

Bullish Evidence

Langfristig

No Evidence

Stimmung

By Acuity

5 / 351 Ranking in Gesundheitswesen

Nachrichtenstimmung

Sehr starke bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Teleflex Inc

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
help-icon Live chat